CSPC Pharmaceutical Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHJTF research report →
About the company
CSPC Pharmaceutical Group Limited operates as an investment holding company with a core focus on the research, development, manufacturing, and global commercialization of pharmaceutical products. Its extensive operations span the People's Republic of China, other Asian markets, the Americas, Europe, and various international territories. The company segments its business into Finished Drugs, Bulk Products, and Functional Food and Others.
- CEO
- Lei Cai
- IPO
- 2010
- Employees
- 21,400
- HQ
- Shijiazhuang, CN
Price Chart
- Market Cap
- $11.18B
- P/E
- 20.89
- P/S
- 3.09
- P/B
- 2.40
- EV/EBITDA
- 12.53
- Div Yield
- 3.62%
- Gross Margin
- 65.59%
- Op Margin
- 15.26%
- Net Margin
- 14.92%
- ROE
- 11.47%
- ROIC
- 8.49%
- Revenue
- $25.33B · -12.64%
- Net Income
- $3.78B · -12.59%
- EPS
- $0.33 · -10.81%
- Op Income
- $3.87B
- FCF YoY
- 128.76%
- 52W High
- $1.39
- 52W Low
- $0.54
- 50D MA
- $1.07
- 200D MA
- $1.04
- Beta
- 0.72
- Avg Volume
- 160
Get TickerSpark's AI analysis on CHJTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CHJTF coverage
Recent articles, reports, and earnings notes.
No research on CHJTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CHJTF report →Similar companies
Peers in the same neighborhood.